Karyopharm Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.About KPTI
Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A.
KPTI Key Statistics
Stock Snapshot
With a market cap of 36.29M, Karyopharm Therapeutics(KPTI) trades at $1.61. The stock has a price-to-earnings ratio of -0.12.
On 2026-09-14, Karyopharm Therapeutics(KPTI) stock traded between a low of $1.21 and a high of $1.64. Shares are currently priced at $1.61, which is +33.1% above the low and -1.8% below the high.
The Karyopharm Therapeutics(KPTI)'s current trading volume is 6.74M, compared to an average daily volume of 1.65M.
During the past year, Karyopharm Therapeutics(KPTI) stock moved between $1.21 at its lowest and $10.99 at its peak.
During the past year, Karyopharm Therapeutics(KPTI) stock moved between $1.21 at its lowest and $10.99 at its peak.
KPTI News
Karyopharm Therapeutics ( (KPTI) ) has shared an announcement. On September 10, 2026, Karyopharm entered a forbearance agreement and limited waiver with its le...
Analyst ratings
83%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.